Use of serological surveys to generate key insights into the changing global landscape of infectious disease

The Lancet

Volumn 388, Issue 10045, 2016, Pages 728-730

  Metcalf, C Jessica E ^a,b   Farrar, Jeremy ^c   Cutts, Felicity T ^d   Basta, Nicole E ^b,e   Graham, Andrea L ^a,b   Lessler, Justin ^f   Ferguson, Neil M ^g   Burke, Donald S ^h   Grenfell, Bryan T ^a,b  

^a PRINCETON UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF MINNESOTA   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

2009 H1N1 INFLUENZA; ANTIBODY RESPONSE; EPIDEMIC; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION; INFECTION SENSITIVITY; INTESTINE INFECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; SEROLOGY; VACCINATION; BLOOD; COMMUNICABLE DISEASE; HEALTH; IMMUNOLOGY; SPECIMEN HANDLING;

ANTIBODIES; COMMUNICABLE DISEASES; GLOBAL HEALTH; HUMANS; SEROLOGIC TESTS; SPECIMEN HANDLING;

EID: 84962359530     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30164-7     Document Type: Note

References (14)

1. 1 Fine, PE, Herd immunity: history, theory, practice. Epidemiol Rev 15 (1993), 265–302.
2. 2 Bjørnstad, ON, Finkenstädt, BF, Grenfell, BT, Dynamics of measles epidemics: estimating scaling of transmission rates using a time series SIR model. Ecol Monogr 72 (2002), 169–184.
3. 3 Van Kerkhove, MD, Ferguson, NM, Epidemic and intervention modelling—a scientific rationale for policy decisions? Lessons from the 2009 influenza pandemic. Bull World Health Organ 90 (2012), 306–310.
4. 4 Boni, MF, Chau, NV, Dong, N, et al. Population-level antibody estimates to novel influenza A/H7N9. J Infect Dis 208 (2013), 554–558.
5. 5 Drakeley, CJ, Corran, PH, Coleman, PG, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 102 (2005), 5108–5113.
6. 6 Cutts, FT, Izurieta, HS, Rhoda, DA, Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys. PLoS Med, 10, 2013, e1001404.
7. 7 Uttenthal, A, Parida, S, Rasmussen, TB, Paton, DJ, Haas, B, Dundon, WG, Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Expert Rev Vaccines 9 (2010), 73–87.
8. 8 Goldstein, ST, Zhou, F, Hadler, SC, Bell, BP, Mast, EE, Margolis, HS, A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34 (2005), 1329–1339.
9. 9 Cutts, FT, Vynnycky, E, Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol 28 (1999), 1176–1184.
10. 10 Lammie, PJ, Moss, DM, Brook Goodhew, E, et al. Development of a new platform for neglected tropical disease surveillance. Int J Parasitol 42 (2012), 797–800.
11. 11 National Oceanic and Atmospheric Administration. ARGO profiling CTD floats. Data region: global. http://floats.pmel.noaa.gov/dataselect/select.php?area=GLOBAL, 2014 (accessed Dec 14, 2015).
12. 12 Tee, KK, Lam, TT-Y, Chan, YF, et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol 84 (2010), 3339–3350.
13. 13 Lessler, J, Riley, S, Read, JM, et al. Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS Pathog, 8, 2012, e1002802.
14. 14 Chen, RT, Markowitz, LE, Albrecht, P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 162 (1990), 1036–1042.